Clear Secure's Healthcare Push Tests Moat Expansion—Retention Slump Adds Near-Term Pressure

Clear Secure's core business is built on a durable moat. Its platform connects passengers to the cards in their wallet, creating a classic network effect where the value for each user increases as more people join. This is the same model that powered the success of payment networks and social platforms. The company's regulatory and security certifications further fortify this position. CLEAR1 is Kantara-certified for NIST IAL2 and AAL2, a significant technical and compliance hurdle that embeds the platform into electronic health records and portals, directly reducing the manual identity checks that plague healthcare systems.

The strategic move into healthcare, exemplified by the partnership with Ochsner Health, a major nonprofit system with 47 hospitals, is a test of whether this moat can be successfully leveraged into a new, high-growth vertical. The initial results are promising: more than 10,000 patients have reset passwords using CLEAR1, with Ochsner reporting a 93% success rate. This demonstrates the platform's ability to solve a real pain point-identity recovery-while simultaneously strengthening security. The partnership is a logical extension, applying a proven identity verification model to a sector that is itself investing heavily in identity management, as noted by CLEAR's own communications.

The bottom line is that Clear Secure possesses a wide moat in identity verification. The combination of network effects, high switching costs for integrated systems, and a regulatory/security advantage creates a formidable barrier to entry. Its expansion into healthcare is not a diversification into a new market, but rather an application of its core competency to a large, underserved vertical. The Ochsner partnership is a strong early signal that this moat can be effectively deployed beyond its initial airport focus.

Financial Quality: Growth, Retention, and Cash Flow

The numbers tell a story of powerful operational leverage, but also of a business facing a classic growth-versus-retention tension. On one side, the company is executing with discipline. Adjusted EBITDA surged 58.1% to $79.9 million, a figure that reflects effective cost management across salaries, R&D, and general and administrative expenses. This is the hallmark of a business scaling efficiently. The top-line momentum is clear as well, with total revenue growing 16.7% to $240.8 million in the fourth quarter, and projections calling for 2026 revenue growth of 16.3% to $1.05 billion.

Yet the quality of that growth is under scrutiny. The most telling metric for a subscription or membership model is customer retention. Here, the data shows a concerning trend. The gross dollar retention rate fell by 210 basis points year-over-year to 86.4%. For a value investor, this is a red flag. It means that for every dollar of revenue generated from existing customers last year, the company is now retaining only about 86 cents. This decline, coupled with a 2.7% year-over-year decline in annual CLEAR+ Member usage, suggests the business is losing some of its stickiness. The cumulative enrollment growth has also slowed for three straight quarters, indicating the easy wins in acquiring new users are fading.

The bottom line is a business generating strong cash flow to reinvest, but one that must now prove it can compound that cash flow by keeping its existing customers. The projected 28% increase in free cash flow for 2026 is a positive signal, showing the company is converting its revenue into cash. However, the sustainability of that cash generation depends on whether the retention metrics can stabilize or improve. A high retention rate is the engine of compounding; without it, growth becomes more expensive and less predictable. The current trajectory suggests the company is in a phase where it must work harder to retain its base even as it adds new members.

Valuation: Price, Intrinsic Value, and the Margin of Safety

The current price presents a classic value investor's dilemma: a high multiple priced for perfection, yet a discounted cash flow model suggesting the stock is trading below its future cash flow value. The market is clearly rewarding Clear Secure's growth story, but the question is whether the premium is justified by the durability of that growth.

The forward P/E ratio of 43.05 is the most immediate red flag. This multiple, significantly above the S&P 500 average, prices in near-flawless execution for years to come. It leaves no room for operational missteps, slower-than-expected expansion into healthcare, or any erosion in the already-stressed customer retention metrics. As a comparison, the stock trades at a 43.8x P/E ratio versus a peer average of 23.6x, highlighting its premium valuation. This is the price of admission for a high-growth story.

Yet, when viewed through a pure cash flow lens, the picture shifts. A discounted cash flow model suggests the stock is trading below its estimated future cash flow value by more than 20%. This divergence between a high earnings multiple and a below-fair-value DCF is a key tension. It implies the market is currently valuing the company based on its current profitability, while the DCF model is betting on the massive future cash flows that the company's expansion into healthcare and broader identity verification could generate. For a patient investor, this gap represents the potential margin of safety-if the company can deliver on its growth trajectory, the current price may be a foothold.

The stock's recent performance underscores the risk of this setup. Shares have rallied 72.6% over the past year and are now near their 52-week high of $50.46. This momentum makes the stock vulnerable to volatility and any stumble in growth expectations. A high multiple combined with a stock at its peak creates a narrow margin of error. The company must continue to execute flawlessly to justify the price.

The bottom line is that Clear Secure's valuation is a bet on the future. The high P/E ratio demands perfection, while the DCF model offers a buffer if the company's long-term cash flow story unfolds. For a value investor, the margin of safety here is thin. It exists only if the business can successfully leverage its wide moat into healthcare and stabilize its customer retention, thereby proving the high-growth thesis. Until then, the price offers little cushion.

Catalysts, Risks, and the Long-Term View

The investment thesis now hinges on a few key catalysts and the metrics that will signal whether Clear Secure can compound value over the long cycle. The primary test is the successful scaling of the Ochsner partnership, particularly the rollout of patient account creation. The initial phase-password recovery for over 10,000 patients with a 93% success rate-is a strong proof of concept. The next phase, however, is where the moat's transferability will be truly tested. Expanding CLEAR1 to support patient account creation within MyOchsner represents a deeper integration into a healthcare system's core workflow. If this phase delivers similar success, it will validate the company's strategy of applying its identity verification platform to a large, high-growth vertical. The scale of Ochsner's system-47 hospitals, 370 clinics, serving 1.6 million patients-means even a modest penetration could significantly boost non-aviation revenue and membership growth.

Key risks remain. The most persistent is the continued decline in customer retention, with the gross dollar retention rate falling to 86.4%. This metric is the engine of compounding; without it, growth becomes more expensive and less predictable. Execution challenges in new verticals like healthcare are another risk. While the partnership is promising, scaling a platform across a vast, complex healthcare network introduces operational friction that could slow adoption or increase costs. Finally, the high valuation multiple creates a narrow margin of error. The stock's forward P/E of 43.05 prices in near-flawless execution, leaving no room for missteps.

For investors, the leading indicators are clear. Quarterly updates on enrollment growth and, more critically, the gross dollar retention rate will be the primary signals of business health. A stabilization or improvement in retention would be a major positive. Similarly, tracking the contribution of non-aviation revenue to total growth will show how effectively the moat is being leveraged beyond airports. The analyst consensus of a Buy, with a price target near the current level, reflects a belief in the catalysts but also acknowledges the risks. The bottom line is that Clear Secure is at an inflection point. The Ochsner partnership is the near-term catalyst that will test its growth model. The long-term view depends on whether the company can use this success to build a broader, more resilient business, all while proving it can retain its existing members. The current price demands it deliver.